Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock: Prophylactic Versus Bail-Out Strategy
Life · 19.02.2023 · 13 (2) · 582
DOI: 10.3390/life13020582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 19.02.2023. Verfasst von Darko Radakovic und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr-University Bochum, 32545 Bad Oeynhausen, Germany. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Access Publication Fund of the Ruhr University Bochum.
Abstract (Originalsprache)
Background
The benefit of prophylactic left ventricular (LV) unloading during venoarterial extracorporeal membrane oxygenation (VA-ECMO) in selected patients at risk of developing LV distension remains unclear.
Methods
We enrolled 136 patients treated with Impella pump decompression during VA-ECMO therapy for refractory cardiogenic shock. Patients were stratified by specific indication for LV unloading in the prophylactic vs. bail-out group. The bail-out unloading strategy was utilized to treat LV distension in VA-ECMO afterload-associated complications. The primary endpoint was all-cause 30-day mortality after VA-ECMO implantation. The secondary endpoint was successful myocardial recovery, transition to durable mechanical circulatory support (MCS), or heart transplantation.
Results
After propensity score matching, prophylactic unloading was associated with a significantly lower 30-day mortality risk (risk ratio 0.38, 95% confidence interval 0.23–0.62, and p < 0.001) and a higher probability of myocardial recovery (risk ratio 2.9, 95% confidence interval 1.48–4.54, and p = 0.001) compared with the bail-out strategy. Heart transplantation or durable MCS did not differ significantly between groups.
Conclusions
Prophylactic unloading compared with the bail-out strategy may improve clinical outcomes in selected patients on VA-ECMO. Nevertheless, randomized trials are needed to validate these results.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr-University Bochum, 32545 Bad Oeynhausen, Germany.
- Clinic for General and Interventional Cardiology/Angiology, Heart and Diabetes Center NRW, Ruhr-University Bochum, 32545 Bad Oeynhausen, Germany.
- Lukas Krankenhaus Bünde Medizinische Klinik II-Innere Medizin und Kardiologie Bünde Germany, 32257 Bünde, Germany.
ORCID-Profile: Armin Zittermann, Sebastian V Rojas, Dragan Opacic, Henrik Fox
Förderung
- Open Access Publication Fund of the Ruhr University Bochum
Zitieren
APA
Radakovic, D., Zittermann, A., Rojas, S. V., Opacic, D., Razumov, A., Prashovikj, E., Fox, H., Schramm, R., Morshuis, M., Rudolph, V., Gummert, J., Flottmann, C., & Deutsch, M. A. (2023). Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock: Prophylactic Versus Bail-Out Strategy. Life, 13(2), 582. https://doi.org/10.3390/life13020582
Vancouver
Radakovic D, Zittermann A, Rojas SV, Opacic D, Razumov A, Prashovikj E, et al. Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock: Prophylactic Versus Bail-Out Strategy. Life. 2023;13(2):582. doi:10.3390/life13020582
BibTeX
@article{Radakovic2023,
author = {Radakovic, Darko and Zittermann, Armin and Rojas, Sebastian V and Opacic, Dragan and Razumov, Artyom and Prashovikj, Emir and Fox, Henrik and Schramm, René and Morshuis, Michiel and Rudolph, Volker and Gummert, Jan and Flottmann, Christian and Deutsch, Marcus-André},
title = {Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock: Prophylactic Versus Bail-Out Strategy},
journal = {Life},
year = {2023},
volume = {13},
number = {2},
pages = {582},
doi = {10.3390/life13020582}
}
EUVIMED